Similar articles for PMID: 9613516

Year	Number of Results
1910	1
1986	1
1989	1
1990	2
1992	3
1994	3
1995	3
1996	6
1997	10
1998	6
1999	3
2000	4
2001	6
2002	10
2003	4
2004	7
2005	6
2006	6
2007	5
2008	2
2009	2
2010	2
2011	6
2012	3
2013	4
2014	4
2015	4
2016	2
2020	2
2021	1
2022	0

1

An organ-preserving selective arterial chemotherapy strategy for head and neck cancer.

Kerber CW, Wong WH, Howell SB, Hanchett K, Robbins KT. Kerber CW, et al. AJNR Am J Neuroradiol. 1998 May;19(5):935-41. AJNR Am J Neuroradiol. 1998. PMID: 9613516 Free PMC article. Clinical Trial.

2

Targeted chemoradiation for advanced head and neck cancer: analysis of 213 patients.

Robbins KT, Kumar P, Wong FS, Hartsell WF, Flick P, Palmer R, Weir AB 3rd, Neill HB, Murry T, Ferguson R, Hanchett C, Vieira F, Bush A, Howell SB. Robbins KT, et al. Head Neck. 2000 Oct;22(7):687-93. doi: 10.1002/1097-0347(200010)22:7<687::aid-hed8>3.0.co;2-w. Head Neck. 2000. PMID: 11002324 Clinical Trial.

3

Rapid superselective high-dose cisplatin infusion for advanced head and neck malignancies.

Robbins KT, Storniolo AM, Kerber C, Seagren S, Berson A, Howell SB. Robbins KT, et al. Head Neck. 1992 Sep-Oct;14(5):364-71. doi: 10.1002/hed.2880140505. Head Neck. 1992. PMID: 1399569

4

Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.

Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT. Madasu R, et al. Arch Otolaryngol Head Neck Surg. 1997 Sep;123(9):978-81. doi: 10.1001/archotol.1997.01900090094014. Arch Otolaryngol Head Neck Surg. 1997. PMID: 9305250

5

[Present role and future prospect of superselective intra-arterial infusion chemotherapy for head and neck cancer].

Yokoyama J. Yokoyama J. Gan To Kagaku Ryoho. 2002 Feb;29(2):169-75. Gan To Kagaku Ryoho. 2002. PMID: 11865620 Review. Japanese.

6

Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: the Memphis experience.

Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB. Robbins KT, et al. Int J Radiat Oncol Biol Phys. 1997 May 1;38(2):263-71. doi: 10.1016/s0360-3016(97)00092-8. Int J Radiat Oncol Biol Phys. 1997. PMID: 9226312 Clinical Trial.

7

A novel organ preservation protocol for advanced carcinoma of the larynx and pharynx.

Robbins KT, Fontanesi J, Wong FS, Vicario D, Seagren S, Kumar P, Weisman R, Pellitteri P, Thomas JR, Flick P, Palmer R, Weir A 3rd, Kerber C, Murry T, Ferguson R, Los G, Orloff L, Howell SB. Robbins KT, et al. Arch Otolaryngol Head Neck Surg. 1996 Aug;122(8):853-7. doi: 10.1001/archotol.1996.01890200043010. Arch Otolaryngol Head Neck Surg. 1996. PMID: 8703389

8

[Usefulness of CT-angiography for superselective intra-arterial chemotherapy for advanced head and neck cancers].

Yokoyama J. Yokoyama J. Gan To Kagaku Ryoho. 2002 Nov;29(12):2302-6. Gan To Kagaku Ryoho. 2002. PMID: 12484060 Japanese.

9

Radiotherapy with concomitant continuous cisplatin infusion for unresectable tumors of the upper aerodigestive tract: results of a phase I study.

Bachaud JM, Chatelut E, Canal P, Albin N, Yardeni E, David JM, Serrano E, Daly-Schveitzer N. Bachaud JM, et al. Am J Clin Oncol. 1997 Feb;20(1):1-5. doi: 10.1097/00000421-199702000-00001. Am J Clin Oncol. 1997. PMID: 9020278 Clinical Trial.

10

Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.

Spring PM, Valentino J, Arnold SM, Sloan D, Kenady D, Kudrimoti M, Haydon RC 3rd, Lee C, Given C, Mohiuddin M, Regine WF. Spring PM, et al. Cancer. 2005 Oct 15;104(8):1765-71. doi: 10.1002/cncr.21368. Cancer. 2005. PMID: 16149090 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed